Skip to main content

CITADEL ADVISORS LLC

Position in KZIA — Kazia Therapeutics Ltd

CIK 1423053 MIAMI, FL

Position in KZIA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$401,405
+$375,401 QoQ
Shares Held
28,509
+2256.1% QoQ
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 35 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KZIA Over Time

Shares Held

Position Value (USD)

Derivatives in KZIA

reported options exposure · as of Jun 30, 2026
CallValue
$1,070,080
CallShares
76,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. KZIA ranks #279 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KZIA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $401,405 28,509
2026-06-30 $1,070,080 76,000
2024-09-30 $33,884 78,800
2024-09-30 $26,004 60,476
2024-06-30 $5,520 24,000
2024-06-30 $1,050 4,566
2023-12-31 $968 2,200
2023-12-31 $5,635 12,809
2022-09-30 $23,650 21,500
2022-06-30 $95,629 22,769
2022-06-30 $267,540 63,700
2021-12-31 $84,200 10,000
2021-09-30 $199,062 17,585
2021-09-30 $288,660 25,500
2021-06-30 $125,991 12,778